Elisabeth van Persijn van Meerten
- Name
- Drs. E.L. van Persijn van Meerten
- Telephone
- +31 71 526 3495
- e.l.van.persijn.van.meerten@umail.leidenuniv.nl
- Faculteit Geneeskunde
- Divisie 2
- Radiologie
- Ende, R.P.J. van den; Rigter, L.S.; Kerkhof, E.M.; Meerten, E.L.V. van; Rijkmans, E.C.; Lambregts, D.M.J.; Triest, B. van; Leerdam, M.E. van; Staring, M.; Marijnen, C.A.M. & Heide, U.A. van der (2019), MRI visibility of gold fiducial markers for image-guided radiotherapy of rectal cancer, Radiotherapy and Oncology 132: 93-99.
- Poelgeest, M.I.E. van; Welters, M.J.P.; Esch, E.M.G. van; Stynenbosch, L.F.M.; Kerpershoek, G.; Meerten, E.L.V. van; Hende, M. van den; Lowik, M.J.G.; Berends-van der Meer, D.M.A.; Fathers, L.M.; Valentijn, A.R.P.M.; Oostendorp, J.; Fleuren, G.J.; Melief, C.J.M.; Kenter, G.G. & Burg, S.H. van der (2013), HPV16 synthetic long peptide (HPV16-SLP) vaccination therapy of patients with advanced or recurrent HPV16-induced gynecological carcinoma, a phase II trial, Journal of Translational Medicine 11.
- Iersel, L.B.J. van; Koopman, M.; Velde, C.J.H.V. de; Mol, L.; Meerten, E.L.V.P. van; Hartgrink, H.H.; Kuppen, P.J.K.; Vahrmeijer, A.L.; Nortier, J.W.R.; Tollenaar, R.A.E.M.; Punt, C. & Gelderblom, H. (2010), Management of isolated nonresectable liver metastases in colorectal cancer patients: a case-control study of isolated hepatic perfusion with melphalan versus systemic chemotherapy, Annals of Oncology 21(8): 1662-1667.
- Iersel, L.B.J. van; Koopman, M.; Velde, C.J.H.V. de; Mol, L.; Meerten, E.L.V.P. van; Hartgrink, H.H.; Kuppen, P.J.K.; Vahrmeijer, A.L.; Nortier, J.W.R.; Tollenaar, R.A.E.M.; Punt, C. & Gelderblom, H. (2010), Management of isolated nonresectable liver metastases in colorectal cancer patients: a case-control study of isolated hepatic perfusion with melphalan versus systemic chemotherapy, Annals of Oncology 21(8): 1662-1667.
- Meerten, E.L.V. van; Gelderblom, H. & Bloem, J.L. (2010), RECIST revised: implications for the radiologist. A review article on the modified RECIST guideline, European Radiology 20(6): 1456-1467.
- van Iersel LBJ, Hoekman EJ, Gelderblom H, Vahrmeijer AL, van Meerten ELV, Tijl FGJ, Hartgrink HH, Kuppen PJK, Nortier JWR, Tollenaar RAEM & van de Velde CJH (2008), Isolated hepatic perfusion with 200 mg melphalan for advanced noncolorectal liver metastases, Annals of Surgical Oncology 15(7).
- van Iersel LBJ, Gelderblom H, Vahrmeijer AL, van Meerten ELV, Tijl FGJ, Putter H, Hartgrink HH, Kuppen PJK, Nortier JWR, Tollenaar RAEM & van de Velde CJH (2008), Isolated hepatic melphalan perfusion of colorectal liver metastases: outcome and prognostic factors in 154 patients, Annals of Oncology 19(6).
- van Iersel LBJ, Verlaan MR, Vahrmeijer AL, van Meerten ELV, Tijl FGJ, Sparidans RW, Gelderblom H, Kuppen PJK, Tollenaar RAEM & van de Velde CJH (2007), Hepatic artery infusion of high-dose melphalan at reduced flow during isolated hepatic perfusion for the treatment of colorectal metastases confined to the liver: A clinical and pharmacologic evaluation, EJSO - European Journal of Surgical Oncology 33(7).
- Teeuwisse WM, Geleijns J, Broerse JJ, Obermann WR & Van Meerten ELV (2001), Patient and staff dose during CT guided biopsy, drainage and coagulation, British Journal of Radiology 74(884).
- Petersein J, Spinazzi A, Giovagnoni A, Soyer P, Terrier F, Lencioni R, Bartolozzi C, Grazioli L, Chiesa A, Manfredi R, Marano P, van Meerten ELV, Bloem JL, Petre C, Marchal G, Greco A, McNamara MT, Heuck A, Reiser M, Laniado M, Claussen C, Daldrup HE, Rummeny E, Kirchin MA, Pirovano G & Hamm B (2000), Focal liver lesions: Evaluation of the efficacy of gadobenate dimeglumine in MR imaging - A multicenter phase III clinical study.
- Jurik A, Petersen J, Jessen KA, Bongartz G, Geleijns J, Golding SJ, Leonardi M, van Meerten EV, Panzer W, Shrimpton PC & Tosi G (2000), Clinical use of image quality criteria in computed tomography: A pilot study, Radiation Protection Dosimetry 90(1-2).
- Jessen KA, Bongartz G, Geleijns J, Golding SJ, Jurik AG, Leonardi M, van Meerten EV, Panzer W, Shrimpton PC & Tosi G (2000), Quality criteria development within the fourth framework research programme: Computed tomography, Radiation Protection Dosimetry 90(1-2).
- Wasser MNJM, Pijl MEJ, van Meerten ELV, Gratama JWC & Bloem JL (1999), Can inversion-recovery gradient- and spin-echo T2-weighted MR imaging be an alternative to fast spin-echo imaging with fat suppression? Response, Radiology 212(1): 291-291.
- Turkenburg JL, Pijl MEJ, van Meerten ELV, Hermans J & Bloem JL (1999), MRI of liver metastases: Limitation of spleen-liver model in optimizing pulse sequences, Journal of Magnetic Resonance Imaging 9(3): 369-372.
- van Rossum AB, van Erkel AR, van Meerten ELVP, Ton ERTA, Rebergen SA & Pattynama PMT (1998), Accuracy of helical CT for acute pulmonary embolism: ROC analysis of observer performance related to clinical experience, European Radiology 8(7): 1160-1164.
- Pijl MEJ, Wasser MNJM, van Meerten ELV, Gratama JWC, van de Velde CJH, Hermans J, Elevelt A & Bloem JL (1998), Comparison of inversion-recovery gradient- and spin-echo and fast spin-echo techniques in the detection and characterization of liver lesions, Radiology 209(2): 427-434.